The risk of primary sclerosing cholangitis (PSC) could be significantly reduced by consuming coffee according to the latest Mayo Clinic study presented at the Digestive Disease Week 2013 conference in Orlando, Fla.
- Cirrhosis of liver
- Biliary cancer
- Liver failure
“While rare, PSC has extremely detrimental effects,” says study author Craig Lammert, M.D., a Mayo Clinic gastroenterologist. “We’re always looking for ways to mitigate risk, and our first-time finding points to a novel environmental factor that also might help us to determine the cause of this and other devastating autoimmune diseases.”
The study was conducted on two groups in U.S. In on group patients with PCS and primary biliary cirrhosis (PBC) were included and in the second group health volunteers were enrolled. The findings of this study suggested that risk of PCS was less in those patients who consume coffee but this risk reduction was not found in patients with PBC.
The study suggests PSC and PBC differ more than originally thought, Konstantinos Lazaridis, M.D., a Mayo Clinic hepatologist and senior study author says: “Moving forward, we can look at what this finding might tell us about the causes of these diseases and how to better treat them.”
This study was financed by National Institutes of Health.
Source: Mayo Clinic
Copyright 2012 Medimoon.com. All rights reserved. No part of this site can be reproduced without our written permission.